Dr. Murali Jayaraman, is currently working as Head, Formulation and Drug product process development at Biologics Unit, Dr. Reddy's Laboratories Ltd. Murali completed Ph.D., in Biochemistry in the area protein misfolding and aggregation at University of Madras. He did postdoctoral work at University of Tennessee and University of Pittsburgh in the area of mechanistic understanding and prevention of protein aggregation in Huntington’s disease. His pharmaceutical journey started during 2010 at Pfizer, St. Louis, USA in the area of formulation development for novel protein molecules using biophysical tools. Later, he worked as a chief research scientist at Hospira (A Pfizer company), Chennai, wherein he had built the formulation and DP process development capability for biosimilars. Murali has over 20 years of research experience, developed novel formulations for monoclonal antibodies, fusion proteins, pegylated proteins and bispecific antibodies. He has 23 publications in peer reviewed journals, 45 patents were filed and 15 patents were granted covering formulations, DP process and test methods. Murali is experienced in developing liquid and lyophilized formulations with protein concentrations up to 200mg/mL and combinations products with safety device and autoinjectors.